Incidence, prognostic factors, and outcomes of venous thromboembolism in critically ill patients: data from two prospective cohort studies
Open Access
- 12 January 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Critical Care
- Vol. 25 (1), 1-9
- https://doi.org/10.1186/s13054-021-03457-0
Abstract
The objective of this study was to describe the prevalence, incidence, prognostic factors, and outcomes of venous thromboembolism in critically ill patients receiving contemporary thrombosis prophylaxis. We conducted a pooled analysis of two prospective cohort studies. The outcomes of interest were in-hospital pulmonary embolism or lower extremity deep vein thrombosis (PE-LDVT), in-hospital nonleg deep vein thrombosis (NLDVT), and 90-day mortality. Multivariable logistic regression analysis was used to evaluate the association between predefined baseline prognostic factors and PE-LDVT or NLDVT. Cox regression analysis was used to evaluate the association between PE-LDVT or NLDVT and 90-day mortality. A total of 2208 patients were included. The prevalence of any venous thromboembolism during 3 months before ICU admission was 3.6% (95% CI 2.8–4.4%). Out of 2166 patients, 47 (2.2%; 95% CI 1.6–2.9%) developed PE-LDVT and 38 patients (1.8%; 95% CI 1.2–2.4%) developed NLDVT. Renal replacement therapy (OR 3.5 95% CI 1.4–8.6), respiratory failure (OR 2.0; 95% CI 1.1–3.8), and previous VTE (OR 3.6; 95% CI 1.7–7.7) were associated with PE-LDVT. Central venous catheters (OR 5.4; 95% CI 1.7–17.8) and infection (OR 2.2; 95% CI 1.1–4.3) were associated with NLDVT. Occurrence of PE-LDVT but not NLDVT was associated with increased 90-day mortality (HR 2.7; 95% CI 1.6–4.6, respectively, 0.92; 95% CI 0.41–2.1). Thrombotic events are common in critically ill patients, both before and after ICU admittance. Development of PE-LDVT but not NLDVT was associated with increased mortality. Prognostic factors for developing PE-LDVT or NLDVT despite prophylaxis can be identified at ICU admission and may be used to select patients at higher risk in future randomized clinical trials. NCT03773939.Keywords
This publication has 36 references indexed in Scilit:
- Pulmonary embolism in mechanically ventilated patients requiring computed tomographyCritical Care Medicine, 2012
- Dalteparin versus Unfractionated Heparin in Critically Ill PatientsThe New England Journal of Medicine, 2011
- How I treat postthrombotic syndromeBlood, 2009
- Immortal time bias in critical care research: Application of time-varying Cox regression for observational cohort studies*Critical Care Medicine, 2009
- Multiple imputation for missing data in epidemiological and clinical research: potential and pitfallsBMJ, 2009
- Upper vs. lower extremity deep vein thrombosis: outcome definitions of venous thromboembolism for clinical predictor rules or risk factor analyses in hospitalized patientsJournal of Thrombosis and Haemostasis, 2009
- Upper extremity deep vein thrombosis not the same disease at a different siteJournal of Thrombosis and Haemostasis, 2008
- How should variable selection be performed with multiply imputed data?Statistics in Medicine, 2008
- The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational StudiesAnnals of Internal Medicine, 2007
- Incidence of Asymptomatic Pulmonary Embolism in Moderately to Severely Injured Trauma PatientsThe Journal of Trauma and Acute Care Surgery, 2004